BioCorRx Inc (QB) (BICX) Börsenkurse

BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCrave... BioCorRx Inc., through its subsidiaries, develops and provides innovative treatment programs for substance use and other related disorders. The Beat Addiction Recovery Program is a medication-assisted treatment (MAT) program for substance use disorder that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The Company's majority owned subsidiary BioCorRx Pharmaceuticals Inc. is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Specifically, the Company is developing an implantable naltrexone (BICX104) with the goal of future regulatory approval with the Food and Drug Administration. For more information on BICX, visit www.BioCorRx.com. Mehr anzeigen